IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients

Phase II Study of the Anti–Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Non–Small-Cell Lung Cancer

(2009) Daniel D. Karp et al.   JOURNAL OF CLINICAL ONCOLOGY

Gene-Expression Signatures in Breast Cancer

(2009) Christos Sotiriou et al.   NEW ENGLAND JOURNAL OF MEDICINE

Insulin-Like Growth Factor 1 Receptor Targeted Therapeutics: Novel Compounds and Novel Treatment Strategies for Cancer Medicine

(2009) Madeleine Hewish et al.   Recent Patents on Anti-Cancer Drug Discovery

Transforming growth factor-β gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer

(2008) Cédric Coulouarn et al.   HEPATOLOGY

Insulin-Like Growth Factor-I Activates Gene Transcription Programs Strongly Associated With Poor Breast Cancer Prognosis

(2008) Chad J. Creighton et al.   JOURNAL OF CLINICAL ONCOLOGY

The Role of Endocrine Insulin-Like Growth Factor-I and Insulin in Breast Cancer

(2008) Danielle Lann et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

Regulation of Breast Cancer Metastasis by IGF Signaling

(2008) Deepali Sachdev   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

Human microvascular endothelial cells are sensitive to IGF-I but resistant to insulin at the receptor level

(2008) G.S. Johansson et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Stromal gene expression predicts clinical outcome in breast cancer

(2008) Greg Finak et al.   NATURE MEDICINE